Neurology

Within Neurology, across the last 5 years, there’s been an increased emphasis on mental health and funding within this area. Growing areas of interest within the market include ADHD and depression, which has resulted in Pharmaceuticals like Methylphenidates growing in popularity; however, it has also resulted in supply chain disruption where there is an increased strain.

We understand different approaches required across different disease areas such as mental health, psychiatry, SZ, MS, Parkinson’s etc. such as partnering with key customers such as mental health centres, NHS trusts and ICB health boards.

We spend the time needed to thoroughly screen individuals with strong technical and clinical experience who can sell on value-added benefits. We also look for those with industry-specific relationships with KOL’s such as Neurologists, prescribing Pharmacists and Referrers who can play a part in driving your company’s growth within the sector.

So if you need someone to thoroughly screen your options and make the process simple, get in touch with our specialist team.